{"log_id": 3569844945569171675, "direction": 0, "words_result_num": 45, "words_result": [{"probability": {"variance": 0.034313, "average": 0.858897, "min": 0.398989}, "location": {"width": 1080, "top": 52, "height": 38, "left": 315}, "words": "(对于急性性白血病患者化疗和骨髓移值时)应用药前,建议对采焦进行体"}, {"probability": {"variance": 0.013351, "average": 0.922529, "min": 0.560307}, "location": {"width": 1142, "top": 95, "height": 38, "left": 253}, "words": "外实验,以确认本药是古促进白血细胞曾多。同时,应定期进行山液查,发现幼稚细"}, {"probability": {"variance": 0.029059, "average": 0.910185, "min": 0.530475}, "location": {"width": 178, "top": 141, "height": 34, "left": 251}, "words": "增多时应停药"}, {"probability": {"variance": 0.021278, "average": 0.908777, "min": 0.421479}, "location": {"width": 1075, "top": 185, "height": 43, "left": 317}, "words": "8骨髓异常增生综合征中,由干已知伴有幼稚细胞增条的类型有转化为性白血病前"}, {"probability": {"variance": 0.020119, "average": 0.936723, "min": 0.475484}, "location": {"width": 1110, "top": 228, "height": 45, "left": 248}, "words": "危验性,因此应月本药时,建议对采集细胞进行体外实验,以实纫细胞集落无增多现象"}, {"probability": {"variance": 0.013125, "average": 0.935234, "min": 0.646888}, "location": {"width": 239, "top": 276, "height": 34, "left": 248}, "words": "3.应时注意事项"}, {"probability": {"variance": 0.018275, "average": 0.940089, "min": 0.367032}, "location": {"width": 712, "top": 319, "height": 34, "left": 310}, "words": "(1)本品为预充式注射器包装,一次用完,可重复使用"}, {"probability": {"variance": 0.020645, "average": 0.930224, "min": 0.439645}, "location": {"width": 950, "top": 363, "height": 38, "left": 308}, "words": "2)静脉的注时,与葡萄糖溶液或生理盐水混合后滴注,与其他药物用"}, {"probability": {"variance": 0.043595, "average": 0.852836, "min": 0.39041}, "location": {"width": 420, "top": 406, "height": 34, "left": 319}, "words": "3)静脉给药,速变应尽量缓慢"}, {"probability": {"variance": 0.00089, "average": 0.976326, "min": 0.907825}, "location": {"width": 207, "top": 447, "height": 34, "left": 246}, "words": "4.其他注意事项"}, {"probability": {"variance": 0.025857, "average": 0.881779, "min": 0.501078}, "location": {"width": 1084, "top": 491, "height": 41, "left": 310}, "words": "1)有银告指出,再生障碍性贫们及先天性中粒细胞减少症惠者,应用柱细胞集落刺"}, {"probability": {"variance": 0.008731, "average": 0.952391, "min": 0.616296}, "location": {"width": 756, "top": 536, "height": 34, "left": 248}, "words": "激因子后,有转为骨异常增生综合征成急性白血病的病例"}, {"probability": {"variance": 0.017173, "average": 0.946711, "min": 0.475352}, "location": {"width": 1075, "top": 575, "height": 47, "left": 317}, "words": "2)有报告指出给再生障性贫血、骨髓异常增生综合征及先天性中性粒细抱减少症思"}, {"probability": {"variance": 0.01805, "average": 0.915771, "min": 0.532108}, "location": {"width": 701, "top": 621, "height": 38, "left": 248}, "words": "者应用粒细胞刺激因子后,有的病侧发生了染色体异常"}, {"probability": {"variance": 0.031162, "average": 0.884136, "min": 0.371091}, "location": {"width": 1068, "top": 666, "height": 43, "left": 326}, "words": "()有接告指出粒细胞刺因子在体外或体内实验,对多种人膀胀及骨瘤细胞株"}, {"probability": {"variance": 0.028889, "average": 0.886977, "min": 0.601158}, "location": {"width": 203, "top": 710, "height": 34, "left": 248}, "words": "具有促进的倾向"}, {"probability": {"variance": 0.008454, "average": 0.952775, "min": 0.665444}, "location": {"width": 324, "top": 753, "height": 34, "left": 244}, "words": "[孕归及哺乳期妇女用药]"}, {"probability": {"variance": 0.019706, "average": 0.921481, "min": 0.51946}, "location": {"width": 847, "top": 792, "height": 43, "left": 306}, "words": "小宜用于妊娠或可能怀孕的妇女妊娠中的用药安全性尚末确定"}, {"probability": {"variance": 0.02088, "average": 0.862829, "min": 0.655405}, "location": {"width": 150, "top": 840, "height": 31, "left": 242}, "words": "L儿童用药]"}, {"probability": {"variance": 0.027897, "average": 0.903832, "min": 0.413442}, "location": {"width": 1039, "top": 881, "height": 41, "left": 344}, "words": "对早产儿、新生儿及婴幼儿用药的安全性尚确定,建议不用该药(使用经验较少"}, {"probability": {"variance": 0.002815, "average": 0.977209, "min": 0.771348}, "location": {"width": 477, "top": 925, "height": 34, "left": 296}, "words": "2.儿童用药时应密切观察、慎重用药"}, {"probability": {"variance": 0.004087, "average": 0.940903, "min": 0.804892}, "location": {"width": 210, "top": 966, "height": 38, "left": 242}, "words": "老年患者用药]"}, {"probability": {"variance": 0.011363, "average": 0.94422, "min": 0.488026}, "location": {"width": 1075, "top": 1009, "height": 47, "left": 299}, "words": "通常老年患者的生理机能〔血机能、肝、肾功能》低下,注意用量用药间隔时问"}, {"probability": {"variance": 0.024169, "average": 0.887042, "min": 0.535453}, "location": {"width": 324, "top": 1057, "height": 34, "left": 242}, "words": "观察患老状态,慎重给药"}, {"probability": {"variance": 0.013163, "average": 0.590261, "min": 0.475533}, "location": {"width": 36, "top": 986, "height": 111, "left": 1580}, "words": "冷四"}, {"probability": {"variance": 0.000387, "average": 0.99026, "min": 0.942169}, "location": {"width": 194, "top": 1098, "height": 36, "left": 255}, "words": "药物相互作用]"}, {"probability": {"variance": 0.019455, "average": 0.92102, "min": 0.406984}, "location": {"width": 728, "top": 1144, "height": 36, "left": 301}, "words": "尚完全清定。对促进白细胞释放之药物(如钾剂)应慎用"}, {"probability": {"variance": 0.000592, "average": 0.986312, "min": 0.932297}, "location": {"width": 150, "top": 1187, "height": 31, "left": 239}, "words": "[药物过量]"}, {"probability": {"variance": 0.029981, "average": 0.913532, "min": 0.401189}, "location": {"width": 1094, "top": 1228, "height": 45, "left": 294}, "words": "当使用本品超过安全剂量时,会出现尿血,尿蛋白阳性,血清碱性磷酸酶明显提"}, {"probability": {"variance": 0.018273, "average": 0.938743, "min": 0.440993}, "location": {"width": 1148, "top": 1269, "height": 47, "left": 237}, "words": "高,但在五周恢复期后各项指标构可恢复正常。当注射本品剂量严重超过安全剂量时,会出"}, {"probability": {"variance": 0.011861, "average": 0.953695, "min": 0.44775}, "location": {"width": 1135, "top": 1315, "height": 41, "left": 237}, "words": "现食欲减退,体重偏低,活动减弱等现象,出现尿隐血,尿蛋白阳性;肝脏出现明显药变"}, {"probability": {"variance": 0.010896, "average": 0.960547, "min": 0.615203}, "location": {"width": 470, "top": 1359, "height": 38, "left": 237}, "words": "这些变化可以在恢复期后消除或减轻"}, {"probability": {"variance": 0.004947, "average": 0.955579, "min": 0.815681}, "location": {"width": 146, "top": 1402, "height": 34, "left": 239}, "words": "[临床试验"}, {"probability": {"variance": 0.023661, "average": 0.927883, "min": 0.376749}, "location": {"width": 1089, "top": 1445, "height": 47, "left": 292}, "words": "临床试验结果表明:本品可明显减轻化疗所致WBC和ANC下程度,缩短TEC和ANO"}, {"probability": {"variance": 0.007705, "average": 0.956765, "min": 0.554014}, "location": {"width": 1151, "top": 1486, "height": 50, "left": 235}, "words": "降至正常值以下吃持续时间,促进WBC和ANC减少的早日恢复,有助于化疗按期进行,且不"}, {"probability": {"variance": 1e-06, "average": 0.998795, "min": 0.997289}, "location": {"width": 146, "top": 1534, "height": 31, "left": 235}, "words": "良反应轻微"}, {"probability": {"variance": 0.000201, "average": 0.988867, "min": 0.960869}, "location": {"width": 137, "top": 1576, "height": 34, "left": 235}, "words": "[药理作用"}, {"probability": {"variance": 0.021168, "average": 0.929973, "min": 0.360747}, "location": {"width": 1094, "top": 1617, "height": 52, "left": 292}, "words": "本品为利用基因重组技术生产的人粒细胞刺因子(hG-CSF)与天然产品相比:生物"}, {"probability": {"variance": 0.020553, "average": 0.919109, "min": 0.498332}, "location": {"width": 1148, "top": 1658, "height": 54, "left": 235}, "words": "活性在体内外基本一致。G-CSF是调节骨髓中检系造血的主要细胞因子之一,选择性作用于"}, {"probability": {"variance": 0.023118, "average": 0.915849, "min": 0.393713}, "location": {"width": 934, "top": 1703, "height": 47, "left": 232}, "words": "粒系造血祖细胞,促进普殖、分化,并可增加粒系中分化细的功能"}, {"probability": {"variance": 2.6e-05, "average": 0.994445, "min": 0.984901}, "location": {"width": 173, "top": 1749, "height": 34, "left": 235}, "words": "[药代动力学]"}, {"probability": {"variance": 0.018214, "average": 0.920097, "min": 0.465379}, "location": {"width": 1080, "top": 1790, "height": 52, "left": 287}, "words": "据资料报道,健成年男性单次静脉或皮下注射本品1Ug/kg其药代动力学参数如下"}, {"probability": {"variance": 0.0217, "average": 0.920921, "min": 0.390991}, "location": {"width": 1137, "top": 1834, "height": 52, "left": 228}, "words": "静给药者的半衰期为1.40小时,AU为21.6ng,hr/ml;皮下注射的半衰期为2.15小时"}, {"probability": {"variance": 0.016814, "average": 0.923719, "min": 0.454963}, "location": {"width": 1146, "top": 1877, "height": 52, "left": 232}, "words": "AIC为11.7g.hr/ml,生物利用度为0.54.连续6天静脉点滴或皮下注射本药后,开始给"}, {"probability": {"variance": 0.010513, "average": 0.952782, "min": 0.489633}, "location": {"width": 1155, "top": 1920, "height": 54, "left": 226}, "words": "药日与第6日的血浆中药物浓无显性差异,无蓄积现象。给色康成年男了静脉点滴本药"}], "language": 3}